Skip to content
World Firm Ledger
Directory

1v1 Institutional Counterparty Comparison

Chain Partners vs InBioGen: Regulation, 6D Ratings & Safety Audit

Deterministic head-to-head benchmarking of Chain Partners (Chain Partners) and InBioGen (InBioGen Co Ltd) across primary regulatory filings, statutory Tier-1 authorisations, 6-Dimension compliance scores, execution software, and warning exposure.

Coverage: Selected financial institution records: Singapore, Asia-Pacific, the Middle East and emerging markets

DETERMINISTIC QUANTITATIVE VERDICTCanonical Pair: chain-partners-10181-vs-inbiogen

Chain Partners and InBioGen are statistically tied in composite 6D scoring (5.0 vs 5.0)

On supervisory breadth, Chain Partners holds 0 active regulated licence(s) (0 Tier-1) out of 0 total filings and 0 warning flag(s), whereas InBioGen holds 0 active regulated licence(s) (0 Tier-1) out of 0 total filings and 0 warning flag(s). Allocators should verify the exact licence numbers, domains, and contracting legal entities below before onboarding.

Direct Verification & Supervisory Regulator Dossiers

Cross-check each counterparty's licence status, registered domains, and issuing regulator frameworks.

Open Licence & Domain Verification Desk →

Chain Partners

0 Regulated · 0 Tier-1

Legal reference: Chain Partners

Issuing Regulator Dossiers

No linked regulator dossier in current directory. Browse all regulators →

InBioGen

0 Regulated · 0 Tier-1

Legal reference: InBioGen Co Ltd

Issuing Regulator Dossiers

No linked regulator dossier in current directory. Browse all regulators →

6-Dimension Quantitative Scorecard Comparison

Head-to-head breakdown across all 6 proprietary evaluation dimensions (0.0–10.0 scale).

6D Compliance Score Visual Profile (0.0 – 10.0)

Chain Partners (5.0)InBioGen (5.0)
Overall 6D100% Composite · Δ 0.0
Chain Partners
5.0
InBioGen
5.0
Risk & Licensing30% Weight · Δ 0.0
Chain Partners
5.0
InBioGen
5.0
Execution Stack20% Weight · Δ +2.0
Chain Partners
1.0
InBioGen
3.0
User Reputation20% Weight · Δ 0.0
Chain Partners
0.0
InBioGen
0.0
Brand Longevity15% Weight · Δ 0.0
Chain Partners
5.0
InBioGen
5.0
Market Influence15% Weight · Δ 0.0
Chain Partners
5.0
InBioGen
5.0
Evaluation DimensionMethodology WeightChain PartnersInBioGenScore DeltaDimension Leader
Overall Composite 6D Score100% Composite5.05.00.0Statistical Tie
Regulatory & Licensing Integrity30% Weight5.05.00.0Statistical Tie
Execution & Software Infrastructure20% Weight1.03.0+2.0InBioGen
User Reputation & Complaint Telemetry20% Weight0.00.00.0Statistical Tie
Institutional Brand Longevity15% Weight5.05.00.0Statistical Tie
Global Market Influence & Footprint15% Weight5.05.00.0Statistical Tie

Visual 6D Compliance Benchmark: Chain Partners vs InBioGen

Vector comparison exhibit contrasting 6-dimension compliance pillars, Tier-1 regulatory authorisations, and exposure telemetry.

Chain Partners vs InBioGen: 6D Compliance & Regulatory Benchmark (2026)
Exhibit: Side-by-side 6D compliance score and regulatory standing comparison between Chain Partners (5.0/10, 0 active licences) and InBioGen (5.0/10, 0 active licences).

Regulatory Standing, Entity & Platform Comparison

Structural comparison of supervisory authorisations, domicile, execution terminals, and risk telemetry.

Audit AttributeChain PartnersInBioGen
Primary Legal NameChain PartnersInBioGen Co Ltd
Regulatory Risk StandingPending ReviewPending Review
Active Regulated / Total Filings0 regulated / 0 total (0 Tier-1)0 regulated / 0 total (0 Tier-1)
Supervisory Regulators & CertificatesNone on fileNone on file
Registered Domicile / AddressKR14F, 61, Digital-ro 26-gil, Guro-gu, Seoul, Republic of Korea
Offered Asset Classes & ServicesMulti-asset financial servicesMulti-asset financial services
Execution Software & TerminalsProprietary / Web PlatformProprietary / Web Platform
Supported Client LanguagesEnglishEnglish
Warning / Exposure Count0 recorded warning(s)0 recorded warning(s)
Direct Licence & Domain CheckVerify Chain Partners →Verify InBioGen →

Explore additional institutional matchups involving peers of Chain Partners and InBioGen.

Frequently Asked Questions: Chain Partners vs InBioGen

Deterministic counterparty comparison answers derived from supervisory records.

Which institution has stronger regulatory oversight: Chain Partners or InBioGen?

Both Chain Partners and InBioGen hold 0 active regulated licence record(s) in our registry. Specifically, Chain Partners maintains 0 recorded filing(s) (none on file) with 0 warning flag(s), whereas InBioGen maintains 0 recorded filing(s) (none on file) with 0 warning flag(s). Always confirm the exact contracting legal subsidiary on the issuing regulator's public register before funding an account.

How do the 6D quantitative compliance scores compare between Chain Partners and InBioGen?

In World Firm Ledger's 6-Dimension scoring matrix (0.0–10.0 scale), Chain Partners records an Overall Score of 5.0 (Risk & Licensing: 5.0, Execution & Software: 1.0, User Reputation: 0.0, Brand Longevity: 5.0, Market Influence: 5.0), compared with InBioGen at 5.0 Overall (Risk & Licensing: 5.0, Execution & Software: 3.0, User Reputation: 0.0, Brand Longevity: 5.0, Market Influence: 5.0).

How do Chain Partners and InBioGen differ in trading platforms and asset classes?

Chain Partners lists multi-asset financial services with execution software [proprietary/web execution], while InBioGen lists multi-asset financial services with execution software [proprietary/web execution]. Counterparties should verify FIX/API connectivity, server routing topology, and negative balance protection per contracting entity.

How can I verify the licences and official domains of Chain Partners and InBioGen?

Use our dedicated verification lookup pages for Chain Partners (/verify/chain-partners-10181) and InBioGen (/verify/inbiogen) to cross-check recorded licence numbers and registered domains, then confirm the exact entity name, permissions, and approved website URL directly on the issuing regulator's official register. Chain Partners currently carries "Pending Review" standing (0 exposure flag(s)) versus "Pending Review" (0 exposure flag(s)) for InBioGen.

Structured against supervisory register snapshots and public regulatory filings. Verify your contracting legal entity and current authorisation status directly on the issuing regulator’s official register before transacting.

Chain Partners vs InBioGen (2026) — Regulation, 6D Score & Safety Audit | World Firm Ledger